![](/img/cover-not-exists.png)
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor
Verschraegen, Claire F, Natelson, Ethan A, Giovanella, Beppino C, Kavanagh, John J, Kudelka, Andrzej P, Freedman, Ralph S, Edwards, Creighton L, Ende, Karen, Stehlin, John SVolume:
9
Journal:
Anti-Cancer Drugs
DOI:
10.1097/00001813-199801000-00004
Date:
January, 1998
File:
PDF, 655 KB
1998